[go: up one dir, main page]

IN2014DN10658A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10658A
IN2014DN10658A IN10658DEN2014A IN2014DN10658A IN 2014DN10658 A IN2014DN10658 A IN 2014DN10658A IN 10658DEN2014 A IN10658DEN2014 A IN 10658DEN2014A IN 2014DN10658 A IN2014DN10658 A IN 2014DN10658A
Authority
IN
India
Prior art keywords
compound
formula
influenza
preparing
useful
Prior art date
Application number
Inventor
Mohammed Homman
Ngarita Kingi
Jan Bergman
Robert Berg
Original Assignee
Vironova Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48444409&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN10658(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vironova Ab filed Critical Vironova Ab
Publication of IN2014DN10658A publication Critical patent/IN2014DN10658A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A compound of formula (I) The compound is useful as an antiviral agent in particular for the treatment of influenza. A method for preparing the compound of formula (I) and a composition comprising the compound of formula (I).
IN10658DEN2014 2012-05-18 2013-05-17 IN2014DN10658A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261648700P 2012-05-18 2012-05-18
US201261659516P 2012-06-14 2012-06-14
US201261666286P 2012-06-29 2012-06-29
US201361774991P 2013-03-08 2013-03-08
PCT/EP2013/060266 WO2013171334A1 (en) 2012-05-18 2013-05-17 Methanethione compounds having antiviral activity

Publications (1)

Publication Number Publication Date
IN2014DN10658A true IN2014DN10658A (en) 2015-08-28

Family

ID=48444409

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10658DEN2014 IN2014DN10658A (en) 2012-05-18 2013-05-17

Country Status (20)

Country Link
US (1) US9359310B2 (en)
EP (1) EP2870141B1 (en)
JP (2) JP6484168B2 (en)
KR (1) KR102092207B1 (en)
CN (1) CN104540810B (en)
AU (1) AU2013261735B2 (en)
BR (1) BR112014028632B1 (en)
CA (1) CA2879816C (en)
CL (1) CL2014003116A1 (en)
DK (1) DK2870141T3 (en)
EA (1) EA029044B1 (en)
ES (1) ES2657942T3 (en)
IL (1) IL235742A0 (en)
IN (1) IN2014DN10658A (en)
MX (1) MX356846B (en)
MY (1) MY169094A (en)
NZ (1) NZ702073A (en)
SG (1) SG11201407703QA (en)
WO (1) WO2013171334A1 (en)
ZA (1) ZA201409220B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6484168B2 (en) * 2012-05-18 2019-03-13 ヴィロノヴァ・インフルエンザ・アクチェボラーグ Methanethione compounds with antiviral activity
CN107056762B (en) * 2016-12-22 2020-08-28 四川百利药业有限责任公司 Bis-carbonyl analogues for use against influenza virus
WO2021204924A1 (en) 2020-04-09 2021-10-14 Vironova Medical Ab Compounds for use in the treatment of hypercytokinemia
WO2021204923A1 (en) 2020-04-09 2021-10-14 Vironova Medical Ab Antiviral agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642390B2 (en) 2001-07-11 2003-11-04 Lexicon Pharmaceuticals, Inc. One step synthesis of 1,2,3-triazole carboxylic acids
AU2004218260A1 (en) 2003-01-28 2004-09-16 Aventis Pharma S.A. N-aryl heteroaromatic products, compositions containing same and use thereof
WO2009131957A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
IN2012DN01254A (en) 2009-08-05 2015-05-15 Versitech Ltd
BR112013007651A2 (en) * 2010-09-28 2019-09-24 Bristol-Myers Squibb Company piperazine analogues with substituted heteroaryl groups as broad spectrum influenza antivirals
EP2484655A1 (en) 2011-02-04 2012-08-08 Vironova AB A thionation process and a thionating agent
JP6484168B2 (en) * 2012-05-18 2019-03-13 ヴィロノヴァ・インフルエンザ・アクチェボラーグ Methanethione compounds with antiviral activity
JP6762767B2 (en) * 2016-06-01 2020-09-30 キヤノン株式会社 Image sensor, image sensor, and image signal processing method

Also Published As

Publication number Publication date
EP2870141B1 (en) 2017-11-22
BR112014028632B1 (en) 2020-01-28
ZA201409220B (en) 2016-08-31
HK1210165A1 (en) 2016-04-15
JP2015517516A (en) 2015-06-22
AU2013261735B2 (en) 2017-07-20
MX356846B (en) 2018-06-18
ES2657942T3 (en) 2018-03-07
MX2014014007A (en) 2015-05-11
CN104540810A (en) 2015-04-22
BR112014028632A8 (en) 2018-04-03
WO2013171334A1 (en) 2013-11-21
KR20150012289A (en) 2015-02-03
EA201401277A1 (en) 2015-04-30
SG11201407703QA (en) 2015-01-29
US9359310B2 (en) 2016-06-07
CA2879816C (en) 2020-07-07
JP2018065817A (en) 2018-04-26
JP6484168B2 (en) 2019-03-13
IL235742A0 (en) 2015-02-01
CN104540810B (en) 2017-01-18
KR102092207B1 (en) 2020-03-23
EA029044B1 (en) 2018-02-28
NZ702073A (en) 2017-07-28
US20150133468A1 (en) 2015-05-14
MY169094A (en) 2019-02-18
CA2879816A1 (en) 2013-11-21
CL2014003116A1 (en) 2015-08-07
AU2013261735A1 (en) 2015-01-22
BR112014028632A2 (en) 2017-06-27
EP2870141A1 (en) 2015-05-13
DK2870141T3 (en) 2018-01-29

Similar Documents

Publication Publication Date Title
PH12015502839B1 (en) Antiviral compounds
PH12016501375A1 (en) Pyridin-2-amides useful as cb2 agonists
PH12015501083B1 (en) Novel pyridine derivatives
MD20150048A2 (en) Pyrrolotriazinone derivatives as PI3K inhibitors
PH12015501843A1 (en) Novel pyrazol derivatives
IN2014DN06104A (en)
UA114655C2 (en) Pyridine-2-amides useful as cb2 agonists
MX2014012477A (en) Pyrrolopyrazone inhibitors of tankyrase.
UA116239C2 (en) Novel pyridine derivatives
MY180050A (en) Novel purine derivatives
MX2014002936A (en) Novel betulinic acid derivatives with antiviral activity.
MX2014004920A (en) Novel pyrazine derivatives.
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
GEP201706626B (en) Synthesis of (s)-nifuratel
UA111333C2 (en) Method for producing l-arginine salt of perindropryl
MY180006A (en) Azetidinyloxyphenylpyrrolidine compounds
GB201107985D0 (en) Process
IN2014DN10658A (en)
IN2015DN00085A (en)
MX2014008918A (en) Novel pyrrolidine derivatives.
MX2014009084A (en) Pyrimidooxazocine derivatives as mtor - inhibitors.
IN2013MU02279A (en)
MX2016007130A (en) Novel method for the synthesis of 7-methoxy-naphthalene-1-carbald ehyde and use thereof in the synthesis of agomelatine.